Home | Welcome to Contract Pharma   
Last Updated Friday, August 1 2014
Print RSS Feed

Breaking News

Related Searches:
August 24, 2010
Larry Kranking has been named president and chief executive officer of Coldstream Laboratories, Inc.   Read More »
August 24, 2010
3SBio, Inc. and Isotechnika Pharma, Inc. have signed a development and commercialization agreement for voclosporin, a next-gen calcineurin inhibitor being developed for the prevention of organ rejection and the treatment of autoimmune diseases.  Read More »
August 24, 2010
Alan P. Breau, Ph.D., has been appointed vice president of MPI Research’s Bioanalytical and Analytical Services (B/AS) division.  Read More »
August 23, 2010
Christopher B. Begley plans to retire from his role as chief executive officer of Hospira Inc.   Read More »
August 23, 2010
Jeffrey M. Zucker has been appointed senior director and global head of patient recruitment at Kendle.   Read More »
August 23, 2010
Alexion Pharmaceuticals’ Rhode Island manufacturing facility (ARIMF) in Smithfield has been approved by the FDA as a second source of commercial supply for Soliris.  Read More »
August 23, 2010
Renard Jackson has been named chief executive officer and president of PrePak Holdings.  Read More »
August 20, 2010
Alan Morgan has been appointed to the position of group president of Clinical Research Services at ICON.  Read More »
August 20, 2010
Pilgrim Software, Inc. has entered a strategic partnership with Global Regulatory Services (GRS), a life science consultancy.   Read More »
August 20, 2010
Avista Capital Partners and Ontario Teachers’ Pension Plan, through its private investor department, Teachers’ Private Capital, have signed an agreement to acquire INC Research, Inc. for a reported $600 million.  Read More »
August 19, 2010
Johnson & Johnson plans to overhaul its quality controls, creating a single support program for its pharmaceutical, medical device and consumer health care divisions.  Read More »
August 19, 2010
Novozymes Biopharma and SAFC, a member of the Sigma-Aldrich Group, have extended by 10 years their joint agreement for LONG R3.   Read More »
August 19, 2010
Human Genome Sciences and GlaxoSmithKline have been granted a priority review designation for Benlysta (belimumab) as a potential treatment for systemic lupus erythematosus (SLE).  Read More »
August 19, 2010
CSL Behring received approval from the FDA for its sBLA to extend the shelf life of Hizentra, Immune Globulin Subcutaneous (Human), 20% Liquid, from 18 months to 24 months.  Read More »
August 18, 2010
Thermo Fisher Scientific has opened a Technology Center in Shanghai, expanding its engineering and development capabilities in China.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On